Medtronic is exiting the diabetes business. The medtech giant said the decision to separate its diabetes business will create a more focused Medtronic, with a more simplified portfolio in high-margin ...

Medtronic's diabetes business was a sweet spot in the company's fiscal first quarter of 2024. After FDA approved the company's MiniMed 780G system with the Guardian 4 sensor in April, analysts and ...

Add Yahoo as a preferred source to see more of our stories on Google. Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, ...

Medtronic markets several products within its diabetes care segment. Perhaps its most important line is its insulin pump franchise. One of the latest iterations of this was the MiniMed 780G, which ...

Medtronic plc (NYSE:MDT) announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial ...

Health tech company Medtronic is acquiring insulin patch pump company EOFlow for $738 million, the company announced Thursday. The acquisition is meant to bolster Medtronic’s diabetes offerings and ...

Mike Mensinger, vice president of engineering at Medtronic Diabetes, talks about how the company’s products and services help people manage diabetes to improve their lives. Medtronic is a medical ...

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience "Patients with diabetes can get overwhelmed by the sheer number of ...

With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc ...

Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, ...